These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12419494)

  • 21. Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease.
    Bhojak TJ; DeKosky ST; Ganguli M; Kamboh MI
    Neurosci Lett; 2000 Jul; 288(1):21-4. PubMed ID: 10869806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E in Southern Italy: protective effect of epsilon 2 allele in early- and late-onset sporadic Alzheimer's disease.
    Panza F; Solfrizzi V; Torres F; Mastroianni F; Colacicco AM; Basile AM; Capurso C; D'Introno A; Del Parigi A; Capurso A
    Neurosci Lett; 2000 Oct; 292(2):79-82. PubMed ID: 10998553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease.
    Scassellati C; Zanardini R; Squitti R; Bocchio-Chiavetto L; Bonvicini C; Binetti G; Zanetti O; Cassetta E; Gennarelli M
    Neurosci Lett; 2004 Feb; 356(2):119-22. PubMed ID: 14746878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conditional inactivation of nicastrin restricts amyloid deposition in an Alzheimer's disease mouse model.
    Sesele K; Thanopoulou K; Paouri E; Tsefou E; Klinakis A; Georgopoulos S
    Aging Cell; 2013 Dec; 12(6):1032-40. PubMed ID: 23826707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep sequencing of the Nicastrin gene in pooled DNA, the identification of genetic variants that affect risk of Alzheimer's disease.
    Lupton MK; Proitsi P; Danillidou M; Tsolaki M; Hamilton G; Wroe R; Pritchard M; Lord K; Martin BM; Kloszewska I; Soininen H; Mecocci P; Vellas B; Harold D; Hollingworth P; Lovestone S; Powell JF
    PLoS One; 2011 Feb; 6(2):e17298. PubMed ID: 21364883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription.
    Laws SM; Hone E; Gandy S; Martins RN
    J Neurochem; 2003 Mar; 84(6):1215-36. PubMed ID: 12614323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.
    Saunders AM; Strittmatter WJ; Schmechel D; George-Hyslop PH; Pericak-Vance MA; Joo SH; Rosi BL; Gusella JF; Crapper-MacLachlan DR; Alberts MJ
    Neurology; 1993 Aug; 43(8):1467-72. PubMed ID: 8350998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity.
    Nacmias B; Bagnoli S; Tedde A; Cellini E; Bessi V; Guarnieri B; Ortensi L; Piacentini S; Bracco L; Sorbi S
    Arch Gerontol Geriatr; 2007; 45(2):201-6. PubMed ID: 17182125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association study between late-onset Alzheimer's disease and the transferrin gene polymorphisms in Chinese.
    Zhang P; Yang Z; Zhang C; Lu Z; Shi X; Zheng W; Wan C; Zhang D; Zheng C; Li S; Jin F; Wang L
    Neurosci Lett; 2003 Oct; 349(3):209-11. PubMed ID: 12951205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese.
    Bian L; Yang JD; Guo TW; Sun Y; Duan SW; Chen WY; Pan YX; Feng GY; He L
    Neurology; 2004 Jul; 63(2):241-5. PubMed ID: 15277615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
    Cui T; Zhou X; Jin W; Zheng F; Cao X
    Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of IL10 promoter polymorphism in Italian Alzheimer's disease.
    Bagnoli S; Cellini E; Tedde A; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
    Neurosci Lett; 2007 May; 418(3):262-5. PubMed ID: 17420099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association study between Alzheimer's disease and genes involved in Abeta biosynthesis, aggregation and degradation: suggestive results with BACE1.
    Clarimón J; Bertranpetit J; Calafell F; Boada M; Tàrraga L; Comas D
    J Neurol; 2003 Aug; 250(8):956-61. PubMed ID: 12928915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
    Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
    Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
    Chalmers K; Wilcock GK; Love S
    Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
    Corder EH; Saunders AM; Strittmatter WJ; Schmechel DE; Gaskell PC; Small GW; Roses AD; Haines JL; Pericak-Vance MA
    Science; 1993 Aug; 261(5123):921-3. PubMed ID: 8346443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genetic factors and a polygenic model of Alzheimer's disease].
    Rogaev EI
    Genetika; 1999 Nov; 35(11):1558-71. PubMed ID: 10624576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The complex interaction between APOE promoter and AD: an Italian case-control study.
    Bizzarro A; Seripa D; Acciarri A; Matera MG; Pilotto A; Tiziano FD; Brahe C; Masullo C
    Eur J Hum Genet; 2009 Jul; 17(7):938-45. PubMed ID: 19172988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The microtubule associated protein Tau gene and Alzheimer's disease--an association study and meta-analysis.
    Russ C; Powell JF; Zhao J; Baker M; Hutton M; Crawford F; Mullan M; Roks G; Cruts M; Lovestone S
    Neurosci Lett; 2001 Nov; 314(1-2):92-6. PubMed ID: 11698154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease.
    Bekris LM; Galloway NM; Millard S; Lockhart D; Li G; Galasko DR; Farlow MR; Clark CM; Quinn JF; Kaye JA; Schellenberg GD; Leverenz JB; Seubert P; Tsuang DW; Peskind ER; Yu CE
    Neurobiol Aging; 2011 Mar; 32(3):556.e13-23. PubMed ID: 21196064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.